In the last trading session, 2.38 million shares of the Evolent Health Inc (NYSE:EVH) were traded, and its beta was 1.43. Most recently the company’s share price was $11.15, and it changed around -$0.1 or -0.89% from the last close, which brings the market valuation of the company to $1.29B. EVH currently trades at a discount to its 52-week high of $35.00, offering almost -213.9% off that amount. The share price’s 52-week low was $11.10, which indicates that the current value has risen by an impressive 0.45% since then. We note from Evolent Health Inc’s average daily trading volume that its 10-day average is 2.73 million shares, with the 3-month average coming to 2.38 million.
Evolent Health Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.14. If we narrow it down even further, the data shows that 0 out of 15 analysts rate the stock as a Sell; another 4 rate it as Overweight. Among the rest, 1 recommended EVH as a Hold, whereas 10 deemed it a Buy, and 0 rated it as Underweight.
Evolent Health Inc (NYSE:EVH) trade information
Instantly EVH has showed a red trend with a performance of -0.89% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 12.98 on recent trading dayincreased the stock’s daily price by 14.1%. The company’s shares are currently down -66.24% year-to-date, but still down -13.70% over the last five days. On the other hand, Evolent Health Inc (NYSE:EVH) is -54.99% down in the 30-day period. We can see from the shorts that 10.82 million shares have been sold at a short interest cover period of 3.46 day(s).
The consensus price target as assigned by Wall Street analysts is $33, which translates to bulls needing to increase their stock price by 66.21% from its current value. Analyst projections state that EVH is forecast to be at a low of $28 and a high of $38.
Evolent Health Inc (EVH) estimates and forecasts
Evolent Health Inc share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -52.51 percent over the past six months and at a -16.09% annual growth rate that is well below the industry average of 24.60%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -13.43%. Evolent Health Inc earnings are expected to increase by -28.91% in 2024, but the outlook is positive 30.00% per year for the next five years.
EVH Dividends
Evolent Health Inc’s next quarterly earnings report is expected to be released in January.
Evolent Health Inc (NYSE:EVH)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 3.95% of Evolent Health Inc shares, and 115.81% of them are in the hands of institutional investors. The stock currently has a share float of 120.57%. Evolent Health Inc stock is held by 368.0 institutions, with WELLINGTON MANAGEMENT GROUP LLP being the largest institutional investor. By 2024-06-30, it held 9.785% of the shares, which is about 11.17 million shares worth $213.55 million.
VANGUARD GROUP INC, with 9.6862% or 11.06 million shares worth $211.39 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
